Transdermal delivery of drugs and cosmetic agents utilizing active-patch technology. The company was acquired by Teikoku.
Company (Alive / Active)
Phone: 651-730-1008
2520 Pilot Knob Road
Suite 100
Mendota Heights, 55120
Minnesota, United States
Total Funding | Date of Last Funding | |
---|---|---|
Travanti Pharma | $7.5M | Jul 17, 2006 |
See all 14 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Company | Status | Description | Investors |
---|---|---|---|
Newton, Massachusetts, United States | IPO / Went public | Chiasma (NASDAQ: CHMA) is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases by developing and commercializing oral medications that were previously available by injection only. The company's lead candidate is octreotide capsules, which has received orphan drug designation from the FDA and EMA. Chiasma is evaluating additional proteins, peptides and small molecule drugs that that are currently only available by injection but could potentially be converted...Show all | Login to see details |
San Diego, California, United States | Alive / Active | Imagine Pharmaceuticals is developing technology to facilitate delivery of drugs to the brain | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions | Nov 09, 2007 | Mar 08, 2011 | Patent |
Abuse potential reduction in abusable substance dosage form | Jan 23, 2004 | Jan 11, 2011 | Patent |
Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis | Apr 22, 2005 | Dec 21, 2010 | Patent |
Dosage control electrode for iontophoresis device | Oct 02, 2003 | Nov 30, 2010 | Patent |